{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:31:23Z","timestamp":1790623883373,"version":"4.1.0"},"reference-count":58,"publisher":"American Association for Cancer Research (AACR)","issue":"17","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-CA139872, R01-CA118839, R01-CA163662"],"award-info":[{"award-number":["R01-CA139872, R01-CA118839, R01-CA163662"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA135075 and CA138340"],"award-info":[{"award-number":["CA135075 and CA138340"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Syndecan-1 (Sdc1\/CD138) expression is linked to disease severity in multiple myeloma, although the causal basis for this link remains unclear. Here we report that capture of the IGF1 receptor (IGF1R) by Sdc1 suppresses ASK1-dependent apoptosis in multiple myeloma cells. Sdc1 binds two different fractions of IGF1R, one that is constitutively active and a second that is activated by IGF1 ligand. Notably, IGF1R kinase activity in both fractions is blocked by synstatinIGF1R (SSTNIGF1R), a peptide that inhibits IGF1R capture by Sdc1, as well as by a truncated peptide (SSTNIGF1R-T) that appears to be specific for multiple myeloma cells. Mechanistically, we show that ASK1 is bound to active IGF1R and inhibited by Tyr and Ser83\/Ser966 phosphorylation. When IGF1R engagement with Sdc1 is blocked by SSTNIGF1R, ASK1 becomes activated, and initiates JNK- and caspase-3\u2013mediated apoptosis. In pharmacologic tests, we find SSTNIGF1R is highly stable in human plasma and displays a half-life of 27 hours in mice, wherein it significantly reduces both the size and neovascularization of CAG myeloma tumor xenografts. Taken together, our results offer a preclinical proof of concept and mechanistic rationale for the exploration of SSTNIGF1R as an experimental therapeutic to dually attack multiple myeloma tumor cell survival and tumor angiogenesis. Cancer Res; 76(17); 4981\u201393. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-16-0232","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T20:51:07Z","timestamp":1467319867000},"page":"4981-4993","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth"],"prefix":"10.1158","volume":"76","author":[{"given":"DeannaLee M.","family":"Beauvais","sequence":"first","affiliation":[{"name":"1Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oisun","family":"Jung","sequence":"additional","affiliation":[{"name":"1Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin."},{"name":"2The Graduate Program in Molecular and Cellular Pharmacology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"3Department of Pathology and the University of Alabama at Birmingham Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph D.","family":"Sanderson","sequence":"additional","affiliation":[{"name":"3Department of Pathology and the University of Alabama at Birmingham Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Rapraeger","sequence":"additional","affiliation":[{"name":"1Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin."},{"name":"2The Graduate Program in Molecular and Cellular Pharmacology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin."},{"name":"4The University of Wisconsin Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"2022061705113084200_bib1","first-page":"1","article-title":"The incidence and epidemiology of plasma cell neoplasms","volume":"13","author":"Bergsagel","year":"1995","journal-title":"Stem Cells"},{"key":"2022061705113084200_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s12032-010-9442-2","article-title":"The evolution and impact of therapy in multiple myeloma","volume":"27","author":"Laubach","year":"2010","journal-title":"Med Oncol"},{"key":"2022061705113084200_bib3","doi-asserted-by":"crossref","first-page":"26085","DOI":"10.1074\/jbc.M109.018473","article-title":"Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors invivo","volume":"284","author":"Khotskaya","year":"2009","journal-title":"J Biol Chem"},{"key":"2022061705113084200_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1309\/617DWB5GNFWXHW4L","article-title":"CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms","volume":"121","author":"O'Connell","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"2022061705113084200_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10585-007-9125-3","article-title":"Syndecan-1: a dynamic regulator of the myeloma microenvironment","volume":"25","author":"Sanderson","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"2022061705113084200_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood.V100.2.610","article-title":"Soluble syndecan-1 promotes growth of myeloma tumors in vivo","volume":"100","author":"Yang","year":"2002","journal-title":"Blood"},{"key":"2022061705113084200_bib7","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1038\/oncsis.2016.5","article-title":"Heparanase-induced shedding of syndecan-1 promotes VEGFR2 activation and an invasive phenotype in multiple myeloma","volume":"5","author":"Jung","year":"2016","journal-title":"Oncogenesis"},{"key":"2022061705113084200_bib8","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood-2007-04-082495","article-title":"The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy","volume":"110","author":"Yang","year":"2007","journal-title":"Blood"},{"key":"2022061705113084200_bib9","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.4049\/jimmunol.1102065","article-title":"Removal of syndecan-1 promotes TRAIL-induced apoptosis in myeloma cells","volume":"188","author":"Wu","year":"2012","journal-title":"J Immunol"},{"key":"2022061705113084200_bib10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2011-12-399808","article-title":"ASK1 promotes apoptosis of normal and malignant plasma cells","volume":"120","author":"Lin","year":"2012","journal-title":"Blood"},{"key":"2022061705113084200_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gad.992302","article-title":"ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats","volume":"16","author":"Nishitoh","year":"2002","journal-title":"Genes Dev"},{"key":"2022061705113084200_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.immuni.2004.06.010","article-title":"XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation","volume":"21","author":"Shaffer","year":"2004","journal-title":"Immunity"},{"key":"2022061705113084200_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1091\/mbc.1.1.27","article-title":"B lymphocytes express and lose syndecan at specific stages of differentiation","volume":"1","author":"Sanderson","year":"1989","journal-title":"Cell Regul"},{"key":"2022061705113084200_bib14","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/MCB.00047-13","article-title":"Integration of apoptosis signal-regulating kinase 1-mediated stress signaling with the Akt\/protein kinase B-IkappaB kinase cascade","volume":"33","author":"Puckett","year":"2013","journal-title":"Mol Cell Biol"},{"key":"2022061705113084200_bib15","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1074\/jbc.M109.064295","article-title":"Reciprocal negative regulation of PDK1 and ASK1 signaling by direct interaction and phosphorylation","volume":"285","author":"Seong","year":"2010","journal-title":"J Biol Chem"},{"key":"2022061705113084200_bib16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.micinf.2005.12.001","article-title":"The ASK1-MAP kinase pathways in immune and stress responses","volume":"8","author":"Hayakawa","year":"2006","journal-title":"Microbes Infect"},{"key":"2022061705113084200_bib17","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1073\/pnas.141224398","article-title":"Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism","volume":"98","author":"Chen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061705113084200_bib18","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1093\/emboj\/20.21.6028","article-title":"Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress","volume":"20","author":"Morita","year":"2001","journal-title":"EMBO J"},{"key":"2022061705113084200_bib19","doi-asserted-by":"crossref","first-page":"13325","DOI":"10.1074\/jbc.M211398200","article-title":"Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1)","volume":"278","author":"Galvan","year":"2003","journal-title":"J Biol Chem"},{"key":"2022061705113084200_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1084\/jem.20081278","article-title":"Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor","volume":"206","author":"Beauvais","year":"2009","journal-title":"J Exp Med"},{"key":"2022061705113084200_bib21","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1242\/jcs.067645","article-title":"Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation","volume":"123","author":"Beauvais","year":"2010","journal-title":"J Cell Sci"},{"key":"2022061705113084200_bib22","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1242\/jcs.02970","article-title":"Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts","volume":"119","author":"McQuade","year":"2006","journal-title":"J Cell Sci"},{"key":"2022061705113084200_bib23","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/febs.12160","article-title":"Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-alphavbeta3 integrin complex in tumorigenesis and angiogenesis","volume":"280","author":"Rapraeger","year":"2013","journal-title":"FEBS J"},{"key":"2022061705113084200_bib24","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/febs.12134","article-title":"Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between alphaVbeta3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis","volume":"280","author":"Rapraeger","year":"2013","journal-title":"FEBS J"},{"key":"2022061705113084200_bib25","first-page":"706","article-title":"CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity","volume":"90","author":"Bataille","year":"2005","journal-title":"Haematologica"},{"key":"2022061705113084200_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.leu.2403997","article-title":"IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma","volume":"20","author":"Chng","year":"2006","journal-title":"Leukemia"},{"key":"2022061705113084200_bib27","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood.V88.6.2250.bloodjournal8862250","article-title":"Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines","volume":"88","author":"Georgii-Hemming","year":"1996","journal-title":"Blood"},{"key":"2022061705113084200_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1247\/csf.13.281","article-title":"Novel purification of vitronectin from human plasma by heparin affinity chromatography","volume":"13","author":"Yatohgo","year":"1988","journal-title":"Cell Struct Funct"},{"key":"2022061705113084200_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","article-title":"HMEC-1: establishment of an immortalized human microvascular endothelial cell line","volume":"99","author":"Ades","year":"1992","journal-title":"J Invest Dermatol"},{"key":"2022061705113084200_bib30","doi-asserted-by":"crossref","first-page":"26103","DOI":"10.1074\/jbc.M115.679084","article-title":"Syndecan-1 and syndecan-4 capture epidermal growth factor receptor family members and the alpha3beta1 integrin via binding sites in their ectodomains: novel synstatins prevent kinase capture and inhibit alpha6beta4-integrin-dependent epithelial cell motility","volume":"290","author":"Wang","year":"2015","journal-title":"J Biol Chem"},{"key":"2022061705113084200_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"2022061705113084200_bib32","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1038\/onc.2008.301","article-title":"JNK signaling in apoptosis","volume":"27","author":"Dhanasekaran","year":"2008","journal-title":"Oncogene"},{"key":"2022061705113084200_bib33","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1242\/jcs.00739","article-title":"Apoptosis - the p53 network","volume":"116","author":"Haupt","year":"2003","journal-title":"J Cell Sci"},{"key":"2022061705113084200_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1677\/erc.1.01172","article-title":"p53 and breast cancer, an update","volume":"13","author":"Lacroix","year":"2006","journal-title":"Endocr Rel Cancer"},{"key":"2022061705113084200_bib35","doi-asserted-by":"crossref","first-page":"e25352","DOI":"10.1371\/journal.pone.0025352","article-title":"RAM, an RGDS analog, exerts potent anti-melanoma effects invitro and invivo","volume":"6","author":"Aguzzi","year":"2011","journal-title":"PLoS ONE"},{"key":"2022061705113084200_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases","volume":"103","author":"Davis","year":"2000","journal-title":"Cell"},{"key":"2022061705113084200_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.cr.7290262","article-title":"Role of JNK activation in apoptosis: a double-edged sword","volume":"15","author":"Liu","year":"2005","journal-title":"Cell Res"},{"key":"2022061705113084200_bib38","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1128\/MCB.00227-07","article-title":"Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1","volume":"27","author":"Fujino","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2022061705113084200_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jcp.10080","article-title":"Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer","volume":"191","author":"Tobiume","year":"2002","journal-title":"J Cell Physiol"},{"key":"2022061705113084200_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1478-811X-7-9","article-title":"The roles of ASK family proteins in stress responses and diseases","volume":"7","author":"Hattori","year":"2009","journal-title":"Cell Commun Signal"},{"key":"2022061705113084200_bib41","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1038\/sj.onc.1202975","article-title":"Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1)","volume":"18","author":"Hoeflich","year":"1999","journal-title":"Oncogene"},{"key":"2022061705113084200_bib42","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.287.5453.664","article-title":"Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1","volume":"287","author":"Urano","year":"2000","journal-title":"Science"},{"key":"2022061705113084200_bib43","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1038\/sj.onc.1208548","article-title":"Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis","volume":"24","author":"Zhang","year":"2005","journal-title":"Oncogene"},{"key":"2022061705113084200_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2022061705113084200_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0092-8674(94)90321-2","article-title":"Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells","volume":"77","author":"Turner","year":"1994","journal-title":"Cell"},{"key":"2022061705113084200_bib46","first-page":"1","article-title":"IGF-I mediated survival pathways in normal and malignant cells","volume":"1766","author":"Kurmasheva","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"2022061705113084200_bib47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ncponc0934","article-title":"Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway\u2013therapeutic perspectives in cancer","volume":"4","author":"Tao","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"2022061705113084200_bib48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1582-4934.2008.00273.x","article-title":"Heat shock proteins: essential proteins for apoptosis regulation","volume":"12","author":"Lanneau","year":"2008","journal-title":"J Cell Mol Med"},{"key":"2022061705113084200_bib49","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2005-03-1158","article-title":"Antimyeloma activity of heat shock protein-90 inhibition","volume":"107","author":"Mitsiades","year":"2006","journal-title":"Blood"},{"key":"2022061705113084200_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1379\/CSC-90R.1","article-title":"C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signal-regulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis","volume":"10","author":"Hwang","year":"2005","journal-title":"Cell Stress Chaperones"},{"key":"2022061705113084200_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/molehr\/gau009","article-title":"Syndecan-1 knockdown in endometrial epithelial cells alters their apoptotic protein profile and enhances the inducibility of apoptosis","volume":"20","author":"Boeddeker","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"2022061705113084200_bib52","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s10495-011-0634-9","article-title":"Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis","volume":"16","author":"Hao","year":"2011","journal-title":"Apoptosis"},{"key":"2022061705113084200_bib53","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.bbadis.2016.03.010","article-title":"Insulin-like growth factor 1 (IGF-1) therapy: mitochondrial dysfunction and diseases","volume":"1862","author":"Sadaba","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2022061705113084200_bib54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2007.08.028","article-title":"Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network","volume":"131","author":"Kang","year":"2007","journal-title":"Cell"},{"key":"2022061705113084200_bib55","first-page":"886","article-title":"Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells","volume":"59","author":"Hosoi","year":"1999","journal-title":"Cancer Res"},{"key":"2022061705113084200_bib56","doi-asserted-by":"crossref","first-page":"36490","DOI":"10.1074\/jbc.M401208200","article-title":"Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity","volume":"279","author":"Huang","year":"2004","journal-title":"J Biol Chem"},{"key":"2022061705113084200_bib57","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-09-3693","article-title":"Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling","volume":"70","author":"Thimmaiah","year":"2010","journal-title":"Cancer Res"},{"key":"2022061705113084200_bib58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1042\/bst0300360","article-title":"Survival-promoting functions of 14-3-3 proteins","volume":"30","author":"Masters","year":"2002","journal-title":"Biochem Soc Trans"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/17\/4981\/2736430\/4981.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/17\/4981\/2736430\/4981.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:59:21Z","timestamp":1655467161000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/76\/17\/4981\/613766\/Syndecan-1-CD138-Suppresses-Apoptosis-in-Multiple"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":58,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2016,8,31]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-16-0232","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22411509.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22411512","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22411506","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22411515.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22411515","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22411512.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22411506.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22411509","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6508242","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508242.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]}}}